Literature DB >> 33207200

RACK1 Mediates NLRP3 Inflammasome Activation by Promoting NLRP3 Active Conformation and Inflammasome Assembly.

Yanhui Duan1, Lingzhi Zhang2, Diego Angosto-Bazarra3, Pablo Pelegrín3, Gabriel Núñez4, Yuan He5.   

Abstract

The NLRP3 inflammasome, a critical component of the innate immune system, induces caspase-1 activation and interleukin (IL)-1β maturation in response to microbial infection and cellular damage. However, aberrant activation of the NLRP3 inflammasome contributes to the pathogenesis of several inflammatory disorders, including cryopyrin-associated periodic syndromes, Alzheimer's disease, type 2 diabetes, and atherosclerosis. Here, we identify the receptor for activated protein C kinase 1 (RACK1) as a component of the NLRP3 complexes in macrophages. RACK1 interacts with NLRP3 and NEK7 but not ASC. Suppression of RACK1 expression abrogates caspase-1 activation and IL-1β release in response to NLRP3- but not NLRC4- or AIM2-activating stimuli. This RACK1 function is independent of its ribosomal binding activity. Mechanistically, RACK1 promotes the active conformation of NLRP3 induced by activating stimuli and subsequent inflammasome assembly. These results demonstrate that RACK1 is a critical mediator for NLRP3 inflammasome activation.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caspase-1; IL-1β; NEK7; NLRP3 inflammasome; RACK1

Year:  2020        PMID: 33207200      PMCID: PMC7709964          DOI: 10.1016/j.celrep.2020.108405

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  54 in total

Review 1.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system.

Authors:  Igor E Brodsky; Noah W Palm; Saheli Sadanand; Michelle B Ryndak; Fayyaz S Sutterwala; Richard A Flavell; James B Bliska; Ruslan Medzhitov
Journal:  Cell Host Microbe       Date:  2010-05-20       Impact factor: 21.023

3.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

4.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.

Authors:  Jianjin Shi; Yue Zhao; Kun Wang; Xuyan Shi; Yue Wang; Huanwei Huang; Yinghua Zhuang; Tao Cai; Fengchao Wang; Feng Shao
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

5.  Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling.

Authors:  Joseph A Duncan; Daniel T Bergstralh; Yanhong Wang; Stephen B Willingham; Zhengmao Ye; Albert G Zimmermann; Jenny Pan-Yun Ting
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

6.  A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation.

Authors:  Jonathan L Schmid-Burgk; Dhruv Chauhan; Tobias Schmidt; Thomas S Ebert; Julia Reinhardt; Elmar Endl; Veit Hornung
Journal:  J Biol Chem       Date:  2015-11-09       Impact factor: 5.157

7.  DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome.

Authors:  Parimal Samir; Sannula Kesavardhana; Deanna M Patmore; Sebastien Gingras; R K Subbarao Malireddi; Rajendra Karki; Clifford S Guy; Benoit Briard; David E Place; Anannya Bhattacharya; Bhesh Raj Sharma; Amanda Nourse; Sharon V King; Aaron Pitre; Amanda R Burton; Stephane Pelletier; Richard J Gilbertson; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2019-09-11       Impact factor: 69.504

8.  Protein kinase D at the Golgi controls NLRP3 inflammasome activation.

Authors:  Zhirong Zhang; Gergö Meszaros; Wan-Ting He; Yanfang Xu; Helena de Fatima Magliarelli; Laurent Mailly; Michael Mihlan; Yansheng Liu; Marta Puig Gámez; Alexander Goginashvili; Adrien Pasquier; Olga Bielska; Bénédicte Neven; Pierre Quartier; Rudolf Aebersold; Thomas F Baumert; Philippe Georgel; Jiahuai Han; Romeo Ricci
Journal:  J Exp Med       Date:  2017-07-17       Impact factor: 17.579

9.  NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component.

Authors:  Hexin Shi; Ying Wang; Xiaohong Li; Xiaoming Zhan; Miao Tang; Maggy Fina; Lijing Su; David Pratt; Chun Hui Bu; Sara Hildebrand; Stephen Lyon; Lindsay Scott; Jiexia Quan; Qihua Sun; Jamie Russell; Stephanie Arnett; Peter Jurek; Ding Chen; Vladimir V Kravchenko; John C Mathison; Eva Marie Y Moresco; Nancy L Monson; Richard J Ulevitch; Bruce Beutler
Journal:  Nat Immunol       Date:  2015-12-07       Impact factor: 25.606

10.  RACK1 depletion in the ribosome induces selective translation for non-canonical autophagy.

Authors:  Hag Dong Kim; EunBin Kong; YongJoong Kim; Jin-Soo Chang; Joon Kim
Journal:  Cell Death Dis       Date:  2017-05-18       Impact factor: 8.469

View more
  14 in total

1.  A Single Amino Acid Residue Defines the Difference in NLRP3 Inflammasome Activation between NEK7 and NEK6.

Authors:  Devon Jeltema; Jihong Wang; Juan Cai; Nathan Kelley; Zhe Yang; Yuan He
Journal:  J Immunol       Date:  2022-03-30       Impact factor: 5.422

Review 2.  How location and cellular signaling combine to activate the NLRP3 inflammasome.

Authors:  Anil Akbal; Alesja Dernst; Marta Lovotti; Matthew S J Mangan; Róisín M McManus; Eicke Latz
Journal:  Cell Mol Immunol       Date:  2022-09-20       Impact factor: 22.096

Review 3.  Inflammasome activation: from molecular mechanisms to autoinflammation.

Authors:  Samuel Lara-Reyna; Emily A Caseley; Joanne Topping; François Rodrigues; Jorge Jimenez Macias; Sean E Lawler; Michael F McDermott
Journal:  Clin Transl Immunology       Date:  2022-07-07

4.  RACK1 Associates with RNA-Binding Proteins Vigilin and SERBP1 to Facilitate Dengue Virus Replication.

Authors:  Alexis Brugier; Mohamed Lamine Hafirrassou; Marie Pourcelot; Morgane Baldaccini; Vasiliya Kril; Laurine Couture; Beate M Kümmerer; Sarah Gallois-Montbrun; Lucie Bonnet-Madin; Pierre-Olivier Vidalain; Constance Delaugerre; Sébastien Pfeffer; Laurent Meertens; Ali Amara
Journal:  J Virol       Date:  2022-03-10       Impact factor: 6.549

Review 5.  Tumour Microenvironment: Roles of the Aryl Hydrocarbon Receptor, O-GlcNAcylation, Acetyl-CoA and Melatonergic Pathway in Regulating Dynamic Metabolic Interactions across Cell Types-Tumour Microenvironment and Metabolism.

Authors:  George Anderson
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

6.  PKA and Epac1 Reduce Nek7 to Block the NLRP3 Inflammasome Proteins in the Retinal Vasculature.

Authors:  Li Liu; Youde Jiang; Jena J Steinle
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

7.  Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation.

Authors:  Umeharu Ohto; Yukie Kamitsukasa; Hanako Ishida; Zhikuan Zhang; Karin Murakami; Chie Hirama; Sakiko Maekawa; Toshiyuki Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-07       Impact factor: 12.779

Review 8.  Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

Authors:  Raquel García-García; Laura Martín-Herrero; Laura Blanca-Pariente; Jesús Pérez-Cabello; Cintia Roodveldt
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

9.  Influenza A Virus Infection Activates NLRP3 Inflammasome through Trans-Golgi Network Dispersion.

Authors:  Kannu Priya Pandey; Yan Zhou
Journal:  Viruses       Date:  2022-01-05       Impact factor: 5.048

10.  Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation.

Authors:  Ana Tapia-Abellán; Diego Angosto-Bazarra; Cristina Alarcón-Vila; María C Baños; Iva Hafner-Bratkovič; Baldomero Oliva; Pablo Pelegrín
Journal:  Sci Adv       Date:  2021-09-15       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.